Trial NCT00625729

View at ClinicalTrials.gov 
Org. Study IDs: 2007LS064
Secondary IDs: MT2007-12 P01CA065493 UMN-0707M13561

Last trial update was posted on 2017-12-28

MeSH Interventions

Aldesleukin Cyclophosphamide Fludarabine Fludarabine phosphate Rituximab

MeSH Conditions

Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Lymphoid Lymphoma Lymphoma, Non-Hodgkin

Other Conditions


Stopping Reasons

No patients exhibited natural killer cell expansion (primary endpoint).

Limitations And Caveats

Study was terminated early due to lack of NK expansion and failure to meet primary outcome.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID